rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2009-12-17
|
pubmed:abstractText |
Raised SERPINE1 plasma levels are related to a 1-bp guanine deletion/insertion (4G5G) polymorphism in the promoter of the SERPINE1 (plasminogen activator inhibitor 1 - PAI1) gene. Evidence suggested that the plasma levels of SERPINE1 modulate the risk of coronary artery disease; furthermore, that the 4G5G polymorphism affects the expression of the SERPINE1 gene.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-9032
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1088-94
|
pubmed:dateRevised |
2010-4-19
|
pubmed:meshHeading |
pubmed-meshheading:20017074-Adult,
pubmed-meshheading:20017074-Aged,
pubmed-meshheading:20017074-Arterial Occlusive Diseases,
pubmed-meshheading:20017074-Case-Control Studies,
pubmed-meshheading:20017074-European Continental Ancestry Group,
pubmed-meshheading:20017074-Female,
pubmed-meshheading:20017074-Gene Frequency,
pubmed-meshheading:20017074-Humans,
pubmed-meshheading:20017074-Macedonia (Republic),
pubmed-meshheading:20017074-Male,
pubmed-meshheading:20017074-Middle Aged,
pubmed-meshheading:20017074-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:20017074-Polymorphism, Genetic,
pubmed-meshheading:20017074-Polymorphism, Single Nucleotide,
pubmed-meshheading:20017074-Risk Factors,
pubmed-meshheading:20017074-Venous Thrombosis
|
pubmed:year |
2009
|
pubmed:articleTitle |
Investigation of SERPINE1 genetic polymorphism in Macedonian patients with occlusive artery disease and deep vein thrombosis.
|
pubmed:affiliation |
Clinic of Cardiology, Faculty of Medicine, Ss. Cyril and Methodius University, Blvd. Krste Petkov Misirkov bb, 1000 Skopje, Republic of Macedonia. ispiroski@gmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|